Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mirum Pharmaceuticals Inc...

    NASDAQ: MIRM · Real-Time Price · USD
    50.69
    0.13 (0.26%)
    At close: Jun 27, 2025, 10:40 AM

    Mirum Pharmaceuticals Statistics

    Share Statistics

    Mirum Pharmaceuticals has 49.53M shares outstanding. The number of shares has increased by 3.99% in one year.

    Shares Outstanding

    n/a
    		 49.53M

    Shares Change (YoY)

    n/a
    		 3.99%

    Shares Change (QoQ)

    n/a
    		 2.1%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 40.03M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,273

    FTD / Avg. Volume

    n/a
    		 0.53%

    Short Selling Information

    The latest short interest is 6.06M, so 12.23% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.06M

    Short % of Shares Out

    n/a
    		 12.23%

    Short % of Float

    n/a
    		 12.23%

    Short Ratio (days to cover)

    n/a
    		 19.9

    Valuation Ratios

    The PE ratio is -22.34 and the forward PE ratio is -102.51. Mirum Pharmaceuticals's PEG ratio is 0.42.

    PE Ratio

    n/a
    		 -22.34

    Forward PE

    n/a
    		 -102.51

    PS Ratio

    n/a
    		 5.83

    Forward PS

    n/a
    		 2.8

    PB Ratio

    n/a
    		 8.71

    P/FCF Ratio

    n/a
    		 210.57

    PEG Ratio

    n/a
    		 0.42
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mirum Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.1, with a Debt / Equity ratio of 1.41.

    Current Ratio

    n/a
    		 3.1

    Quick Ratio

    n/a
    		 2.93

    Debt / Equity

    n/a
    		 1.41

    Debt / EBITDA

    n/a
    		 -6.49

    Debt / FCF

    n/a
    		 34.05

    Interest Coverage

    n/a
    		 -6.12

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,008,646.71

    Profits Per Employee

    n/a
    		 $-263,299.4

    Employee Count

    n/a
    		 334

    Asset Turnover

    n/a
    		 0.5

    Inventory Turnover

    n/a
    		 3.64

    Taxes

    Income Tax

    n/a
    		 1.03M

    Effective Tax Rate

    n/a
    		 -1.19%

    Stock Price Statistics

    The stock price has increased by 52.73% in the last 52 weeks. The beta is 0.95, so Mirum Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.95

    52-Week Price Change

    n/a
    		 52.73%

    50-Day Moving Average

    n/a
    		 44.88

    200-Day Moving Average

    n/a
    		 43.95

    Relative Strength Index (RSI)

    n/a
    		 66.22

    Average Volume (20 Days)

    n/a
    		 427,009

    Income Statement

    In the last 12 months, Mirum Pharmaceuticals had revenue of 336.89M and earned -87.94M in profits. Earnings per share was -1.85.

    Revenue

    n/a
    		 336.89M

    Gross Profit

    n/a
    		 255.25M

    Operating Income

    n/a
    		 -87.61M

    Net Income

    n/a
    		 -87.94M

    EBITDA

    n/a
    		 -48.97M

    EBIT

    n/a
    		 -72.6M

    Earnings Per Share (EPS)

    n/a
    		 -1.85
    Full Income Statement

    Balance Sheet

    The company has 222.5M in cash and 317.76M in debt, giving a net cash position of -95.26M.

    Cash & Cash Equivalents

    n/a
    		 222.5M

    Total Debt

    n/a
    		 317.76M

    Net Cash

    n/a
    		 -95.26M

    Retained Earnings

    n/a
    		 -644.18M

    Total Assets

    n/a
    		 690.25M

    Working Capital

    n/a
    		 283.24M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 10.32M and capital expenditures -993K, giving a free cash flow of 9.33M.

    Operating Cash Flow

    n/a
    		 10.32M

    Capital Expenditures

    n/a
    		 -993K

    Free Cash Flow

    n/a
    		 9.33M

    FCF Per Share

    n/a
    		 0.2
    Full Cash Flow Statement

    Margins

    Gross margin is 75.77%, with operating and profit margins of -26% and -26.1%.

    Gross Margin

    n/a
    		 75.77%

    Operating Margin

    n/a
    		 -26%

    Pretax Margin

    n/a
    		 -25.8%

    Profit Margin

    n/a
    		 -26.1%

    EBITDA Margin

    n/a
    		 -14.54%

    EBIT Margin

    n/a
    		 -26%

    FCF Margin

    n/a
    		 2.77%

    Dividends & Yields

    MIRM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MIRM is $68, which is 34.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $68

    Price Target Difference

    n/a
    		 34.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.28

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist